Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents

Hypertension

Volumn 26, Issue 4, 1995, Pages 696-704

  Papapetropoulos, Andreas ^a   Marczin, Nandor ^a   Mora, Gloria ^a   Milici, Antonio ^a   Murad, Ferid ^b   Catravas, John D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Molecular Geriatrics Corporation   (United States)

Author keywords

cyclic AMP; cyclic GMP; guanylate cyclase; nitroprusside

Indexed keywords

CYCLIC AMP; GUANYLATE CYCLASE; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION REGULATION; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0029147812     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.26.4.696     Document Type: Article

References (51)

1. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest. 1986;78:1-5.
2. Waldman SA, Murad F. cGMP synthesis and function. Pharmacol Rev. 1987;39:163-196.
3. Schmidt HHHW, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanisms of action. Biochim Biophys Acta. 1993;1178:153-175.
4. Glass DB, Frey W, Carr DW, Goldberg ND. Stimulation of human platelet soluble guanylate cyclase by fatty acids. J Biol Chem. 1977; 252:1279-1285.
5. Craven PA, Derubertis FR. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and heme proteins: evidence for the involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. J Biol Chem. 1978;253:8433-8443.
6. Ignarro LJ, Ballot B, Wood KS. Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J Biol Chem. 1984;259:6201-6207.
7. Schmidt HHHW. NO, CO and OH: endogenous soluble guanylyl cyclase-activating factors. FEBS Lett. 1992;307:102-107.
8. Anand-Srivastava MB, Trachte GJ. Atrial natriurctic factor: receptors and signal transduction mechanisms. Pharmacol Rev. 1993;45:455-497.
9. Gerzer R, Bohme E, Hoffman R, Schultz G. Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett. 1981;132:71-74.
10. 2OH: modulation of enzyme responses by heme protein and their nitrosyl derivatives. J Biol Chem. 1979;254: 8213-8222.
11. Craven PA, Derubertis FR. Requirement for heme in the activation of purified guanylate cyclase by nitric oxide. Biochim Biophys Acta. 1983;745:310-321.
12. Nakane M, Saheki S, Kuno T, Ishii K, Murad F. Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung. Biochem Biophys Res Commun. 1988;157: 1139-1147.
13. Nakane M, Aral K, Saheki S, Kuno T, Buechler W, Murad F. Molecular cloning and expression of cDNAs coding for soluble guanylate eyclase from rat lung. J. Biol Chem. 1990;265:16841-16845.
14. Yuen PST, Potter LR, Garbers DL. A new form of guanylyi cyclase is preferentially expressed in rat kidney. Biochemistry. 1990;29: 10872-10878.
15. Harteneck C, Wedel B, Koesling D, Malkewitz J, Bohme E, Schultz G. Molecular cloning of a new alpha subunit of soluble guanylate cyclase: interchangeability of the alpha-subunits of the enzyme. FEBS Lett. 1991;292:217-222.
16. Giuili G, Scholl U, Bulle F, Guellaen G. Molecular cloning of the cDNAs coding for the two subunits of the soluble guanylyl cyclase from human brain. FEBS Lett. 1992;304:83-88.
17. Buechler WA, Nakane M, Murad F. Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem Biophys Res Commun. 1991;174:351-357.
18. Ignarro LJ, Kadowitz PJ. Pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol. 1985;25:171-191.
19. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of cyclic GMP in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 1981;57:946-955.
20. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
21. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 1990;275:87-90.
22. Beasley D, Schwartz JH, Brenner BM. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest. 1991;87:602-608.
23. Xie Q, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992;256:225-228.
24. Kanno K, Hirata Y, Imai T, Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension. 1993;22:34-39.
25. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
26. Katsuki S, Arnold W, Mittal C, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res. 1977;3:23-35.
27. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro LJ. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res. 1979;5: 211-224.
28. 2+ levels in cultured vascular smooth muscle cells. J Biol Chem. 1989;262: 1146-1155.
29. Fiscus R, Rapoport R, Murad F. Endothelium-dependent and nitrovasodilator-induced activation of cyclic GMP dependent protein kinase in rat aorta. J Cyclic Nucleotide Protein Phosphorylation Res. 1983;9:415-425.
30. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
31. Hunter WM, Greenwood FC. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature. 1962;194: 495-496.
32. 125I-labeled succinyl cyclic nucleotide tyrosine methyl esters by high-performance liquid chromatography. Anal Biochem. 1988;168:417-420.
33. Brooker G, Terasaki W, Price M. Gammaflow: a completely automated radioimmunoassay system. Science. 1976;194:270-276.
34. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Tashioka T, Hidaka H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cAMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H89), of PC12 pheochromocytoma cells. J Biol Chem. 1990;265: 5267-5272.
35. Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun. 1987;142:436-440.
36. Bradford M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-253.
37. Ahmad I, Barnstable CJ. Differential laminar expression of particulate and soluble guanylate cyclase genes in rat retina. Exp Eye Res. 1993;56:51-62.
38. Tso JY, Sun X-H, Kao T-H, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 1985;13:2485-2502.
39. Ujiie K, Drewett JG, Yuen PST, Star RA. Differential expression of mRNA for guanylyl cyclase-linked endothelium-derived relaxing factor receptor subunits in rat kidney. J Clin Invest. 1993;91: 730-734.
40. Katz ED, Dong MW. Rapid analysis and purification of polymerase chain reaction products by high-performance liquid chromatography. Biotechniques. 1990;8:546-555.
41. Lewicki JA, Chang B, Murad F. Quantification of guanylate cyclase concentrations by a direct double determinant tandem immunoradiometric assay. J Biol Chem. 1983;258:3509-3515.
42. Shimouchi A, Janssens SP, Bloch DB, Zapol WM, Bloch DB. cAMP regulates soluble guanylate cyclase β1-subunit gene expression in RLF-6 rat fetal lung fibroblasts. Am J Physiol. 1993; 265:L456-L461.
43. Hu ZW, Honda K, Murad F, Hoffman BB. Prolonged exposure to catecholamines enhances sensitivity of smooth muscle relaxation induced by sodium nitroprusside and atriopeptin. J Pharmacol Exp Ther. 1992;260:756-761.
44. De Kimpe SJ, Van Heuven-Nolsen D, Van Amsterdam JGC, Radomski MW, Nijkamp FP. Induction of nitric oxide release by interferon-γ inhibits vasodilation and cGMP increase in bovine isolated mesenteric arteries. J Pharmacol Exp Ther. 1994;268: 910-915.
45. Papapetropoulos A, Marczin N, Catravas JD. Downregulation of nitrovasodilator-induced cGMP accumulation in smooth muscle cells exposed to endotoxin and interleukin-1β. FASEB J. 1994; 8:A556. Abstract.
46. Hirokawa K, O'Shaughnessy K, Moore K, Ramrakha P, Wilkins MR. Induction of nitric oxide synthase in cultured vascular smooth muscle cells: the role of cAMP. Br J Pharmacol. 1994;112:396-402.
47. Imai T, Hirata Y, Kanno K, Marumo F. Induction of nitric oxide synthase by cAMP in rat vascular smooth muscle cells. J Clin Invest. 1994;93:543-549.
48. Muhl H, Kunz D, Pfeilschifter J. Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br J Pharmacol. 1994;112:1-8.
49. Sowa G, Przewlocki R. cAMP analogues and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures. Eur J Pharmacol. 1994;266:125-129.
50. 3 subunits for soluble guanylyl cyclase to human chromosome 4 at q31.3-q33. Hum Genet. 1993;91:257-260.
51. Lennard AC, Fried M. The bidirectional promoter of the divergently transcribed mouse surf-1 and surf-2 genes. Mol Cell Biol. 1991;11:1281-1284.